<DOC>
	<DOCNO>NCT02617095</DOCNO>
	<brief_summary>The purpose study compare efficacy safety T2762 versus Optive® treatment moderate severe Dry Eye Syndrome .</brief_summary>
	<brief_title>Comparison Efficacy Safety T2762 Versus Optive® Treatment Moderate Severe Dry Eye Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<criteria>Signed date informed consent . Male female age ≥ 18 year old . Diagnosis moderate severe dry eye syndrome Pregnancy , lactation . Childbearing potential woman use reliable method contraception surgically sterilise . Inability patient understand study procedure thus inability give informed consent . Noncompliant patient Participation another clinical study time present study . Participation present study exclusion period another clinical study . Already include study . Ward court . Patient covered government health care scheme</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>